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 Black tea is rich in polyphenols and has been shown to have various health benefits; 
however, its components have not yet been clarified in detail. Enzymatic oxidation of 
epigallocatechin-3-O-gallate, the most abundant polyphenol in tea, is thought to contribute 
significantly to the production of black tea polyphenols. We identified theacitrin C, an 
unstable black tea pigment, as an enzymatic oxidation product of epigallocatechin-3-O-gallate. 
Degradation of theacitrin C afforded theacitrinin A and 
2,3,5,7-tetrahydroxychroman-3-O-gallate. Furthermore, theacitrinin B, which was isolated 
from black tea, is deduced to be a degradation product of theacitrin A, the desgalloyl analogue 
of theacitrin C. The structures of theacitrinins A and B were elucidated based on 
spectroscopic data. This is the first time that a degradation product of theacitrin has been 
isolated from black tea. We also examined the influence of esterification of the 
epigallocatechin C-3 hydroxyl group on the decomposition of bicyclo[3.2.1]octane-type 
intermediates. 
 





Plant polyphenols have recently attracted much attention because of their 
health-promoting effects. Black tea, which is one of the most popular beverages worldwide, 
contains abundant polyphenols, has various health benefits,1 and is an important source of 
plant polyphenols for humans. Black tea is manufactured by the fermentation of fresh tea 
leaves (Camellia sinensis). During this process, green tea catechins, (–)-epicatechin (17), 
(–)-epigallocatechin (15), (–)-epicatechin-3-O-gallate (16), and 
(–)-epigallocatechin-3-O-gallate (1), are enzymatically oxidized to afford complex mixtures 
of products.2 
(–)-Epigallocatechin-3-O-gallate (1), which is a catechin present in abundance in tea, is 
known to have a wide range of biological activities.3 Enzymatic oxidation of 1 is thought to 
contribute significantly to the production of black tea polyphenols. Our previous results 
revealed the structures of various enzymatic oxidation products of 1.4 However, some of the 
products were found to be unstable and were insufficiently characterized. In this paper, we 
report the isolation and identification of theacitrin C (5), an unstable black tea pigment, as a 
major enzymatic oxidation product of 1. We then examined the degradation of 5. We also 
describe the isolation of theacitrinin B (9), which is likely produced by degradation of 
theacitrin A (8), found in black tea. Furthermore, we examined the enzymatic oxidation 
products of (–)-epigallocatechin-3-O-acetate (10), to clarify the influence of the hydroxyl 
 5
group at the C-3 position of the C-ring on the oxidation of epigallocatechin derivatives. 
 
2. Results and discussion 
2.1. Production of theacitrin C by enzymatic oxidation of epigallocatechin-3-O-gallate 
An HPLC profile of the enzymatic oxidation reaction mixture of 
(–)-epigallocatechin-3-O-gallate (1) is shown in Fig. 1. Previously, we characterized the 
structures of the three major products, corresponding to peaks 24, as dehydrotheasinensin A 
(2),4a EGCg quinone dimer A (3),4a and EGCg quinone dimer B (4),4b respectively (Scheme 1). 
However, until now, the product corresponding to peak 5 could not be isolated due to its 
instability. Here we report our successful efforts to isolate this unstable product. 
 






Scheme 1. Enzymatic oxidation of epigallocatechin-3-O-gallate (1). 
 
An aqueous solution of 1 was stirred vigorously with Japanese pear fruit homogenate, 
which has a high polyphenol oxidase activity.5 After the reaction was observed to reach 
equilibrium, the mixture was acidified with trifluoroacetic acid (TFA) to inactivate enzyme 
activity and to suppress the degradation of 2. After filtration, the filtrate was applied to 
MCI-gel CHP20P and eluted to afford five fractions. Fraction 3 containing product 5 was 
further purified using Cosmosil 40C18-PREP and YMC-Pack ODS-AQ. 
The molecular formula of 5 was determined to be C44H32O22 by HRFABMS (m/z 
935.1302 [M + Na]+, +1.9 mmu). The 1H and 13C NMR spectra indicated the presence of two 
sets of flavan A- and C-rings, along with two galloyl groups. The remaining 12 carbon signals 
in the 13C NMR spectrum were attributable to the B-rings and consisted of three carbonyl 
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carbons (δC 200.2, 194.5, 177.8), four sp
2 quaternary carbons (δC 173.3, 150.8, 149.5, 118.4), 
two sp2 methines (δC 130.0, 118.4), two sp
3 quaternary carbons (δC 87.2, 50.3), and one sp
3 
methine (δC 57.6). 
1H and 13C NMR data of the B-ring moiety of 5 indicated its similarity to 
the B-ring of theacitrin A (8).6 The molecular formula of 5 (C44H32O22) corresponded to that 
of mono-galloyl substituted theacitrin A. The structure of 5 was therefore presumed to be 
theacitrin A 3-O-gallate, i.e., theacitrin C,6 as shown in Scheme 1. The structure of 5 was 
confirmed using an HMBC experiment, which showed correlations similar to those observed 
in 8.6 
Theacitrins A (8), B, and C (5) were previously isolated from black tea as yellow 
pigments; however, 5 has only been characterized using MS and UV spectroscopic data.6 In 
this paper, the structure of 5 has been characterized for the first time by 1D and 2D-NMR 
spectroscopic analysis. This is also the first report of the isolation of theacitrins from the 
enzymatic oxidation of epigallocatechins.7 
A production mechanism of 5 is proposed, as shown in Scheme 2. The B-ring of 1 is 
oxidized to its o-quinone form (1a), and 1,4-addition between 1 and 1a then occurs to 
generate a C–C bond. Successive oxidation and intramolecular 1,2-addition produces a 





Scheme 2. Proposed mechanism of theacitrin C (5) production. 
 
2.2. Degradation of theacitrin C 
During the final step of black tea manufacture, tea leaves are heated to deactivate 
enzymes and to dry the tea. On heating, theacitrin C (5) present in the tea leaves is likely to 
decompose because of its instability. We therefore examined the degradation products of 5. 
An aqueous solution of 5 was heated at 80 C for 60 min and then analyzed by HPLC. 
Photodiode array detection revealed a decrease in levels of 5, and the decomposition products 
were detected as a broad hump on the HPLC baseline. Reaction in McIlvaine buffer at pH 5.0 
also led to a similar result. However, heating in aqueous solution containing 0.1% TFA (ca. 
pH 1.9) gave products that could be detected as sharp peaks by HPLC analysis. The products 
were purified using Cosmosil 40C18-PREP to afford 6 and 7 (Scheme 3). Based on 
spectroscopic comparison, compound 7 was identified as 
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2,3,5,7-tetrahydroxychroman-3-O-gallate,4a previously isolated from black tea. 
 
Scheme 3. Degradation of theacitrin C (5) to afford theacitrinin A (6) and 
2,3,5,7-tetrahydroxychroman-3-O-gallate (7). 
 
Compound 6 exhibited a [M + Na]+ peak at m/z 603 in MALDI-TOFMS. The 1H and 
13C NMR spectra (Table 1) were similar to those of 5, except for the absence of signals 
arising from one set of flavan A- and C-rings, and a galloyl group. Comparison of the 13C 
NMR and HSQC spectra of 6 with those of 5 showed the presence of a 4,5-di-C-substituted 
pyrogallol ring (δC 156.0, 146.7, 143.2, 133.1, 114.1, 106.8) instead of the 
2,5-cyclohexadien-1-one moiety found in 5. The structure of the B-ring was also confirmed 
by the appearance of HMBC correlations of H-f (δH 6.94) with C-e (δC 55.7), C-g (δC 156.0), 
C-h (δC 133.1), C-j (δC 114.1), and C-i (δC 146.7; 
4J), and the correlations of H-e (δH 4.53) 
with C-f (δC 106.8), C-j, and C-k (δC 143.2) (Table 1). These observations indicated that one 
set of galloylated flavan A- and C-rings, originally attached at C-k of 5, had been eliminated. 
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Thus, the structure of 6 was determined as shown in Scheme 3 and named theacitrinin A. The 
production of 6 and 7 by elimination of the flavan A- and C-rings is thought to be promoted 




H (500 MHz) and 
13
C (125 MHz) NMR data for theacitrinins A (6) and B (9) (in acetone-d 6).
13
C HMBC (H to C)
13
C HMBC (H to C)
2 5.26  (s) 74.1 c, d 4.94 (br s) 76.4 4, c, d, e
3 5.89  (br s) 66.5 4a 4.01 (br s) 64.0 4a
4 2.96  (dd, 2.7, 17.5) 26.0 2, 4a 2.76 (dd, 2.3, 16.9) 29.0 2, 3, 4a, 5, 8a
3.08  (dd, 4.8, 17.5) 2, 4a, 5, 8a 2.82 (dd, 4.4, 16.9) 3, 4a, 5, 8a
4a 99.3 99.1
5 157.7 157.3
6 6.14  (d, 2.3) 97.3 4a, 5, 7, 8 5.94 (d, 2.3) 96.7 4a, 5, 7, 8
7 158.1 157.3
8 6.24  (d, 2.3) 95.9 4a, 6, 7, 8a 5.84 (d, 2.3) 95.4 4a, 6, 7, 8a
8a 155.6 155.3
2' 6.12 (br s) 78.1 3', f, g, k
3' 5.67 (br s) 70.7 4a', galloyl 7
4' 3.05 (br d, 17.6) 26.2 2', 3', 4a', 5', 8a', f (
4
J )
3.26 (dd, 4.6, 17.6) 4a', 5', 8a'
4a' 98.9
5' 157.3
6' 6.09 (d, 2.3) 97.9 4a', 5', 7', 8'
7' 157.6








e 4.53  (s) 55.7 a, c, d, f, j, k 4.76 (br s) 53.8 a, c, d, f, g (
4
J ), j, k, l
f 6.94  (s) 106.8 e, g, h, i (
4







galloyl 1 121.1 120.8
galloyl 2, 6 7.03 (2H, s) 109.9 galloyl 1, 2, 3, 4, 5, 6, 7 7.10 (2H, s) 110.0 galloyl 1, 2, 3, 4, 5, 6, 7
galloyl 3, 5 146.0 145.8
galloyl 4 139.2 139.0
galloyl 7 166.1 166.4
5-OH 8.50 (br s) 4a, 5
a-OH 5.79 (br s) a, e
h-OH 8.74 (br s) g, h, i
galloyl 3, 5-OH 8.28 (2H, br s) galloyl 2, 3, 4, 5, 6
galloyl 4-OH 8.08 (br s) galloyl 3, 5












The degradation products of theacitrins such as 6 are expected to be contained in 
black tea, and we therefore examined the constituents of black tea in detail. Black tea was 
extracted with boiling water, and the extract was successively partitioned with CHCl3, EtOAc, 
and 1-BuOH. The 1-BuOH fraction was separated using a combination of column 
chromatography on Sephadex LH-20, MCI-gel CHP20P, Chromatorex ODS and Toyopearl 
HW-40F, to afford 9, although compound 6 has not been isolated at the present stage. 
1H and 13C NMR spectra of 9 were closely related to those of 6 (Table 1), except for 
the appearance of signals attributable to one set of flavan A- and C-rings and one galloyl 
group. The presence of two sets of galloylated flavan A- and C-rings was supported by the [M 
+ H]+ peak at m/z 761 in the FABMS spectrum. The additional flavan-3-ol moiety in 9 was 
concluded to be attached at C-f, based on the absence of an aromatic singlet signal assigned to 
H-f in 6 (δH 6.94) in 
1H NMR and the down-field shift of C-f observed (9: δC 113.9; 6: δC 
106.8) in 13C NMR. The HMBC correlations between H-2' (δH 6.12) with C-f, C-g (δC 154.0), 
and C-k (δC 140.1) also supported the proposed location of the flavan A- and C-rings in 9. 






Scheme 4. Proposed mechanism of theacitrinin B (9) production from theacitrin A (8). 
 
It is likely that compound 9 was produced by dienone-phenol rearrangement8 of theacitrin 
A (8) (Scheme 4), while compound 6 was produced by the elimination of the flavan-3-ol 
moiety from theacitrin C (5). The degradation mechanisms of theacitrins are similar to those 
of proepitheaflagallin (20), which is produced by the enzymatic oxidation of epigallocatechin 
(15).9 Heating of an aqueous solution of 20 afforded hydroxytheaflavin by dienone-phenol 
rearrangement, and the black tea pigment epitheaflagallin, by elimination of the flavan-3-ol 
moiety.9a It is anticipated that 6 is also contained in black tea. 
This is the first report of the isolation of theacitrin degradation products from black tea. 
These results show that the production and degradation reactions of theacitrins may be 
responsible for the complex mixture of black tea polyphenols. 
 
2.3. Enzymatic oxidation of epigallocatechin-3-O-acetate 
Enzymatic oxidation of (–)-epigallocatechin (15) and 
 13
(–)-epigallocatechin-3-O-gallate (1) affords dehydrotheasinensins C9a and A (2), respectively, 
as major products (Scheme 1). However, enzymatic oxidation of 1 did not afford the 
proepitheaflagallin-type product corresponding to 20, which is one of the oxidation products 
of 15. Conversely, enzymatic oxidation of 15 did not afford the theacitrin-type product 
corresponding to 5.9 Because proepitheaflagallin (20) and theacitrin C (5) are both thought to 
be produced from epigallocatechins via bicyclo[3.2.1]octane-type intermediates, we 
postulated that the presence of a hydroxyl group at C-3 may determine the decomposition 
routes of bicyclo[3.2.1]octane-type intermediates. The presence of galloyl esters may also be 
important because the aromatic ester can interact with the adjacent aromatic ring by π-π 
interactions. We therefore synthesized (–)-epigallocatechin-3-O-acetate (10), which has 
neither a hydroxyl group nor an aromatic ester at C-3, and examined the enzymatic oxidation 
products of 10 and the decomposition of bicyclo[3.2.1]octane-type intermediates.  
(–)-Epigallocatechin-3-O-acetate (10) was synthesized by acetylation of 
(–)-epigallocatechin (15) and subsequent selective hydrolysis of the phenolic acetyl groups. 
Enzymatic oxidation of 10 using Japanese pear fruit homogenate afforded three main products, 
11 (tR = 22.1 min), 12 (tR = 29.5 min) and 13 (tR = 31.2 min), as shown by HPLC (Fig. 2). 
These products were purified by column chromatography to give 11 (44%), 12 (2.3%) and 
13a (2.9%). Product 13 was unstable, and gradually degraded to 13a (tR = 26.7 min) during 
purification process and only 13a could be isolated. 
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Fig. 2. HPLC profile of the enzymatic oxidation products of epigallocatechin-3-O-acetate 
(10). 
 
The molecular formula of 11 was determined to be C34H30O17 by HRFABMS (m/z 
711.1558 [M + H]+, –0.3 mmu). The 1H and 13C-NMR spectra of 11 were very similar to 
those of dehydrotheasinensin A (2),4a except for the appearance of signals due to two acetyl 
groups instead of two galloyl groups. Therefore, 11 was proposed to be dehydrotheasinensin 
C 3,3''-di-O-acetate (Scheme 5), and the structure was confirmed using detailed analysis of 
2D-NMR spectra. The structure was further evidenced by the reduction of 11 with 
dithiothreitol to yield 11a (Fig. 3).4a The absolute configuration at C-2' of 11 was determined 





Scheme 5. Enzymatic oxidation of epigallocatechin-3-O-acetate (10). 
 
 
Fig. 3. Structures of 11a, 11b, and 14. 
 
The molecular formula of 12 was determined to be C34H30O17 by HRFABMS (m/z 
711.1570 [M + H]+, +0.9 mmu). The 1H and 13C-NMR spectra of 12 were very similar to 
those of 3,10 except for the appearance of signals derived from two acetyl groups instead of 
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two galloyl groups. Based on a detailed analysis of 2D-NMR spectra, the structure of 12 was 
determined as shown in Scheme 5.  
The molecular formula of 13a was determined to be C23H18O11 by HRFABMS (m/z 
471.0930 [M + H]+, +0.3 mmu). The 1H and 13C NMR spectra of 13a resembled those of 
theacitrinin A (6), except for the replacement of a galloyl group by an acetyl group. Therefore, 
the structure of 13a was concluded to be that shown in Scheme 5 and confirmed by 2D-NMR 
spectroscopic analysis. 
HPLC analysis with photodiode array detection showed that the UV-vis absorption 
of 13 (λmax: 203, 223 sh, 307 nm, and gradual-slope from ca. 350 to 430 nm) was similar to 
that of theacitrin C (5). Furthermore, HRFABMS spectrum of the mixture of 13 and 13a 
obtained in the process of purification confirmed a molecular formula of C34H28O16 for 13 
[m/z 693.1422 (calcd for C34H29O16, 693.1456)]. These results implied that 13 is a 
theacitrin-type structure with two acetyl groups as shown in Scheme 5. It is probable that 13a 
was produced from 13 by a degradation mechanism similar to the production of theacitrinin A 
(6) from theacitrin C (5). We could not isolate 13 because of its instability, while 5 was 
sufficiently stable to be isolated. This implies that the B-ring moiety of 5 could be stabilized 
by intramolecular stacking with the C-3 galloyl group. 
Enzymatic oxidation of 10 afforded the theacitrin-type product 13; however, no 
proepitheaflagallin-type products were detected. This result confirmed that when the hydroxyl 
 17
group at C-3 of epigallocatechin was esterified, theacitrin-type products were produced. On 
the other hand, when the hydroxyl group at C-3 was not esterified, proepitheaflagallin-type 
products were produced.9 
On enzymatic oxidation, a pyrogallol quinone produced from epigallocatechin was 
coupled with the pyrogallol ring of another epigallocatechin molecule to afford a 
bicyclo[3.2.1]octane-type intermediate (Scheme 6). When the hydroxyl group at C-3 is 
esterified, theacitrin-type structures are produced from the intermediates by rearrangement. 
On the other hand, when the hydroxyl group at C-3 is not esterified, proepitheaflagallin-type 
structures are produced from the intermediate via hemiacetal formation. Theaflavins are also 
produced by condensation of catechol quinones produced by enzymatic oxidation of 
epicatechins with pyrogallol rings of epigallocatechins via bicyclo[3.2.1]octane-type 








Scheme 6. Production pathways of proepitheaflagallin (20), theacitrin C (5), and theaflavins 
via bicyclo[3.2.1]octane-type intermediates. 
 
Some decomposition products of bicyclo[3.2.1]octane-type intermediates, theaflavins, 
theacitrins, and epitheaflagallin, are known as black tea pigments. The results described here 
indicate that the formation of the bicyclo[3.2.1]octane-type skeleton by enzymatic oxidation 
of tea catechins is a key reaction in the production of black tea pigments. We speculate that 
the production and decomposition of bicyclo[3.2.1]octane-type intermediates from tea 
catechins also contribute significantly to the production of structurally unknown black tea 




In this study, we identified theacitrin C (5) as an enzymatic oxidation product of 
epigallocatechin-3-O-gallate (1), and its degradation products were examined. Furthermore, 
theacitrinin B (9), a degradation product of theacitrin A (8), was isolated from black tea. We 
also examined the influence of the hydroxyl group at the C-3 position of the C-ring of 
epigallocatechin on the decomposition reactions of bicyclo[3.2.1]octane-type intermediates. 
The results indicate that the formation of the bicyclo[3.2.1]octane-type skeleton by enzymatic 





1H, 13C NMR, 1H-1H COSY, HSQC, HMBC spectra were measured on a Varian 
UNITYplus 500 (500 MHz for 1H and 125 MHz for 13C NMR), and a JEOL JNM-AL400 
(400 MHz for 1H and 100 MHz for 13C NMR) spectrometer. Chemical shifts were recorded as 
parts per million (ppm) with the solvent signal used as a standard (DMSO-d6, δH 2.49, δC 
39.5; acetone-d6, δH 2.04, δC 29.8; CDCl3, δH 7.24, δC 77.0). Coupling constants are given in 
Hz. Melting points were determined on a micro melting point hot stage apparatus 
(Yanagimoto, Japan) and are uncorrected. FABMS spectra were measured on a JEOL 
JMS-700N spectrometer, and m-nitrobenzyl alcohol or glycerol was used as the matrix. 
MALDI-TOFMS spectra were measured on an Applied Biosystems Voyager-DE PRO, and 
2,5-dihydroxybenzoic acid was used as the matrix. Elemental analyses were measured on a 
Perkin-Elmer 2400 II analyzer. UV/VIS spectra were measured on a JASCO V-560 
spectrophotometer. Optical rotations were measured on a JASCO P-1020 digital polarimeter. 
IR spectra were measured on a JASCO FT/IR-410 spectrophotometer. 
Column chromatography was performed with MCI-gel CHP20P (75150 μm, 
Mitsubishi Chemical, Japan), Sephadex LH-20 (25100 μm, GE Healthcare, Sweden), 
Chromatorex ODS (Fuji Silysia Chemical, Japan), and Toyopearl HW-40F (Tosoh, Japan). 
MPLC was performed with Cosmosil 40C18-PREP (Nacalai Tesque, Japan) and YMC-Pack 
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ODS-AQ (S-50 μm, 12 nm, YMC, Japan). TLC was performed on precoated Kieselgel 60 
F254 plates (0.2 mm thick, Merck, Germany) with toluene/ethyl formate/formic acid (1/7/1, 
v/v) and spots were detected using ultraviolet illumination and by spraying with 2% ethanolic 
FeCl3 or 5% aq H2SO4 reagent followed by heating. Analytical HPLC was performed on a 
Cosmosil 5C18-ARII (Nacalai Tesque, Japan) column (250  4.6 mm i.d.) with gradient 
elution from 4 to 30% (39 min) and from 30 to 75% (15 min) of CH3CN in 50 mM H3PO4 
(flow rate, 0.8 mL/min; temperature: 35 C; detection: JASCO photodiode array detector 
MD-2010). (–)-Epigallocatechin-3-O-gallate and (–)-epigallocatechin were isolated from 
commercial green tea and recrystallized from water. Theasinensin C was prepared as 
described previously.9a 
 
4.2. HPLC analysis of the enzymatic oxidation products of 
(–)-epigallocatechin-3-O-gallate (1) 
 Japanese pear fruits (50 g) were homogenized with 50 mL of H2O and filtered 
through four layers of gauze. The filtrate (1.0 mL) was mixed with an aqueous solution of 
(–)-epigallocatechin-3-O-gallate (1) (10 mg/1.0 mL) and vigorously stirred for 60 min at 
room temperature. After stirring, EtOH (300 μL) was poured into the reaction mixture (100 
μL) and the resulting mixture was then filtered through a membrane filter (0.45 μm). The 
filtered solution (5 μL) was analyzed by analytical HPLC. 
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4.3. Production of theacitrin C (5) by enzymatic oxidation of 
(–)-epigallocatechin-3-O-gallate (1) 
Japanese pear (Pyrus pyrifolia) fruits (150 g) were homogenized with 150 mL of 
H2O and filtered through four layers of gauze. The filtrate (200 mL) was mixed with an 
aqueous solution of (–)-epigallocatechin-3-O-gallate (1) (2.0 g/200 mL) and vigorously 
stirred for 60 min at room temperature. After stirring, the reaction solution was acidified with 
trifluoroacetic acid (TFA) (0.5 mL) and filtered. The filtered solution was then directly 
applied to a column of MCI-gel CHP20P (3  29 cm) and eluted with 0100% aq MeOH 
containing 0.1% TFA (5% stepwise elution, each 200 mL) to yield five fractions: fr. 1 (430.4 
mg), fr. 2 (334.3 mg), fr. 3 (508.1 mg), fr. 4 (463.5 mg), and fr. 5 (228.3 mg). Fr. 1 was 
identified as pure dehydrotheasinensin A (2) from spectroscopic data.4a Other fractions were 
analyzed by HPLC-DAD, and the presence of 2, EGCg quinone dimer A (3) and 1 in fr. 2; 1 
and 5 in fr. 3; and EGCg quinone dimer B (4) in fr. 4 were detected. Fr. 3 was purified by 
MPLC on Cosmosil 40C18-PREP (20  300 mm, 040% aq CH3CN containing 0.05% TFA) 
and YMC-Pack ODS-AQ (20  300 mm, 050% aq MeOH) to give theacitrin C (5) (27.5 mg). 
At all stages of purification, obtained fractions were evaporated under reduced pressure below 
40 C, then lyophilized. 
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4.3.1. Theacitrin C (5) 
A yellow amorphous powder; [α]21D –34.3 (c 0.12, MeOH); Positive FABMS m/z: 913 [M + 
H]+, 935 [M + Na]+; Negative MALDI-TOFMS m/z: 911 [M H]–; HRFABMS m/z: [M + 
Na]+ calcd for C44H32O22Na, 935.1283; found: 935.1302; UV (MeOH) max nm (log ε): 275 
(4.45), and gradual-slope from ca. 350 to 450 nm; IR (dry film) νmax cm
1: 3381, 1731, 1696, 
1607, 1519; 1H NMR (DMSO-d6–CF3COOD, 9:1, 500 MHz) δ 2.45 (1H, br d, J = 17.4 Hz, 
H-4'), 2.66 (2H, m, H-4, 4'), 2.80 (1H, dd, J = 17.4, 4.1 Hz, H-4), 4.30 (1H, s, H-e), 4.40 (1H, 
s, H-2'), 4.86 (1H, br s, H-2), 5.25 (1H, m, H-3'), 5.72 (1H, br s, H-3), 5.97 (1H, s, H-c), 6.01 
(1H, br s, H-6'), 6.05 (1H, br s, H-6), 6.11 (1H, br s, H-8'), 6.15 (1H, br s, H-8), 6.68 (1H, s, 
H-f), 6.72 (2H, s, galloyl H-2', 6'), 6.79 (2H, s, galloyl H-2, 6); 13C NMR 
(DMSO-d6–CF3COOD, 9:1, 125 MHz) δ: 25.7 (C-4), 28.3 (C-4'), 50.3 (C-k), 57.6 (C-e), 63.3 
(C-3'), 65.3 (C-3), 74.7 (C-2), 81.2 (C-2'), 87.2 (C-a), 95.1, 96.8 (C-6, 8), 95.1, 96.6 (C-6', 8'), 
98.0 (C-4a), 98.2 (C-4a'), 109.1 (2C, galloyl C-2, 6), 109.5 (2C, galloyl C-2', 6'), 118.4 (2C, 
C-f, j), 119.3 (galloyl C-1), 119.6 (galloyl C-1'), 130.0 (C-c), 139.0 (galloyl C-4'), 139.3 
(galloyl C-4), 145.5 (2C, galloyl C-3, 5), 145.9 (2C, galloyl C-3', 5'), 149.5 (C-g), 150.8 (C-i), 
155.0, 156.3, 157.1 (4C) (C-5, 7, 8a, 5', 7', 8a'), 165.4 (galloyl C-7'), 165.7 (galloyl C-7), 
173.3 (C-d), 177.8 (C-h), 194.5 (C-l), 200.2 (C-b); HMBC correlations (H to C): H-2/C-c, d; 
H-4/C-2, 4a; H-6/C-4a, 5, 7, 8; H-8/C-4a, 6, 7, 8a; H-2'/C-3', 4', e, f, j, k; H-3'/C-4a', galloyl 
C-7'; H-4'/C-2', 4a'; H-6'/C-4a', 5', 7', 8'; H-8'/C-4a', 6', 7', 8a'; H-c/C-2, a, b, d, e; H-e/C-2', a, 
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c, d, f, j, k, l; H-f/C-2', e, g, h, j, l (4J); galloyl H-3, 5/galloyl C-1, 3, 4, 5, 7; galloyl H-3', 
5'/galloyl C-1', 3', 4', 5', 7'. 
 
4.4. HPLC analysis of the degradation products of theacitrin C (5) 
An aqueous solution of theacitrin C (5) (0.5 mg / 0.2 mL) was heated at 80 C for 60 
min, and then 5 μL of the solution was analyzed by HPLC-DAD. The same procedure was 
also carried out using McIlvaine buffer at pH 5.0 and an aqueous solution containing 0.1% 
TFA (ca. pH 1.9). 
 
4.5. Isolation of the degradation products of theacitrin C (5) in acidic conditions 
An aqueous acidic solution of theacitrin C (5) containing 0.1% TFA (25.5 mg/5.1 
mL) was heated at 80 °C for 60 min. After cooling, the solvent was removed under reduced 
pressure, and the residue was purified by MPLC on Cosmosil 40C18-PREP (20  300 mm, 
030% aq CH3CN containing 0.1% TFA) to afford 6 (11.0 mg, 68%) and 7 (8.4 mg, 86%). 
 
4.5.1 Theacitrinin A (6) 
A pale yellow powder; mp 198–201 C; [α]26D +31.3 (c 0.05, MeOH); MALDI-TOFMS m/z: 
603 [M + Na]+; Anal. Calcd for C28H20O142H2O: C, 54.55; H, 3.92. Found: C, 54.50; H, 3.75; 
UV λmax (MeOH) nm (log ε): 277 (4.10), 293 sh (4.04), 345 sh (3.39); IR dry filmνmaxcm1: 
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3396, 1717, 1707, 1687 (sh), 1618, 1523, 1510, 1472; 1H and 13C NMR data: see Table 1. 
 
4.6. Isolation of theacitrinin B (9) from black tea 
Black tea (600 g), a blend of tea leaves produced in India and Sri Lanka, was 
extracted with boiling water (5 L × 3), and the extract was concentrated. The extract was 
successively partitioned with CHCl3, EtOAc and 1-BuOH. The 1-BuOH fraction (63.4 g) was 
separated into ten fractions (fr. 110) by Sephadex LH-20 column chromatography (5.0 cm  
35 cm, H2OMeOH50% aq acetone). Fr. 6 was further separated using a combination of 
column chromatography with MCI-gel CHP20P (H2OMeOH), Chromatorex ODS (050% 
aq MeOH), Toyopearl HW-40F (40100% aq MeOH), and Sephadex LH-20 (EtOH), to give 
theacitrinin B (9) (57.3 mg). 
 
4.6.1 Theacitrinin B (9) 
 A reddish brown amorphous powder, [α]21D –377.9 (c 0.1, MeOH); FABMS m/z: 761 [M + 
H]+, 783 [M + Na]+, 745 [M –H2O + H]+; Anal. Calcd for C37H28O1811/2H2O: C, 51.69; H, 
4.57. Found: C, 51.58; H, 4.60; UV (MeOH) λmax nm (log ε): 278 (4.21), 290 sh (4.15), 350 




4.7. Synthesis of (–)-epigallocatechin-3-O-acetate (10) 
A solution of (–)-epigallocatechin (15) (4.01 g, 13.1 mmol) in a mixture of acetic 
anhydride (7.5 mL) and pyridine (15 mL) was stirred at room temperature for 8 h. The 
solution was then poured into ice-cold water and filtered. The filtered residue was purified by 
column chromatography on silica gel (CHCl3MeOH, 100:099:1) to give 
(–)-epigallocatechin pentaacetate (1b) (5.30 g, 72%) as a white powder. All physical and 
spectroscopic data of 1b were identical to those reported previously.12 A solution of 1b (4.01 
g, 7.17 mmol) in a mixture of McIlvaine buffer at pH 4.0 (30 mL) and dioxane (30 mL) was 
heated at reflux for 76 h. After cooling, the solvent was removed under reduced pressure. The 
residue was purified by column chromatography using MCI-gel CHP20P (080% aq MeOH) 
and Sephadex LH-20 (0100% aq MeOH), to give (–)-epigallocatechin-3-O-acetate (10) 
(1.49 g, 60%). 
 
4.7.1. (–)-epigallocatechin-3-O-acetate (10) 
A white amorphous powder, [α]19D –62.0 (c 0.11, MeOH); HRFABMS m/z: [M  H]+ calcd 
for C17H17O8, 349.0923; found, 349.0910; UV (MeOH) λmax nm (log ɛ): 270 (3.32); IR (dry 
film) νmax cm
–1: 3340, 1711, 1605, 1513, 1461, 1377; 1H NMR (acetone-d6, 400 MHz) δ: 1.86 
(3H, s, Ac), 2.76 (1H, dd, J = 17.6, 2.4 Hz, H-4), 2.95 (1H, dd, J = 17.6, 4.9 Hz, H-4), 4.94 
(1H, s, H-2), 5.36 (1H, m, H-3), 5.94, 6.04 (each 1H, d, J = 2.4 Hz, H-6, 8), 6.54 (2H, s, H-2', 
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6'), 7.30 (1H, br s, OH at C-4'), 7.87 (2H, s, OH at C-3', 5'), 8.13, 8.34 (each 1H, s, OH at C-5, 
7); 13C NMR (acetone-d6, 100 MHz) δ 20.9 (Ac(CH3)), 26.3 (C-4), 68.9 (C-3), 77.7 (C-2), 
95.8, 96.4 (C-6 and C-8), 98.9 (C-4a), 106.7 (2C, C-2', 6'), 130.5 (C-1'), 133.2 (C-4'), 146.2 
(2C, C-3', 5'), 156,9, 157.4, 157.8 (C-5, 7, 8a), 170.3 (Ac(CO)). 
 
4.8. Enzymatic oxidation of (–)-epigallocatechin-3-O-acetate (10) 
Japanese pear fruits (100 g) were homogenized with 100 mL of H2O and filtered 
through four layers of gauze. The filtrate (93 mL) was mixed with an aqueous solution of 
(–)-epigallocatechin-3-O-acetate (10) (930 mg / 93 mL) and vigorously stirred for 60 min at 
room temperature. After stirring, the reaction solution was acidified with TFA (0.5 mL) and 
insoluble materials were removed by filtration. The filtrate was directly applied to a column 
of MCI-gel CHP-20P (3  29 cm) and eluted with 0100% aq MeOH containing 0.1% TFA 
(5% stepwise elution, each 200 mL) to yield five fractions (fr. 15). Each fraction was 
concentrated in vacuo below 40 C and lyophilized. Fr. 1 (420.1 mg) was pure compound 11. 
Fr. 2 (57.2 mg) was subjected to Chromatorex ODS (2  27 cm, 060% aq MeOH containing 
0.1% TFA) column chromatography to give 12 (10.8 mg). Fr. 3 (217.4 mg) was separated by 
Cosmosil 40C18-PREP (20  300 mm, 4–30% aq CH3CN) and the same column (460% aq 
MeOH) to afford 13a (18.5 mg) and 12 (10.7 mg). 
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4.8.1. Compound 11 
A white amorphous powder; [α]30D –132.4 (c 0.095, MeOH); FABMS m/z: 711 [M  H]+, 
733 [M + Na]+, 749 [M + K]+, 693 [M –H2O + H]+; HRFABMS m/z: [M + H]+ calcd for 
C34H31O17, 711.1561; found, 711.1558; UV (MeOH) λmax nm (log ε): 269 (3.56), 305 (3.30); 
IR (dry film) νmax cm
–1: 3407, 1724, 1633, 1519, 1469, 1379; 1H NMR (500 MHz, acetone-d6) 
δ: 1.85 (3H, s, 3''-OAc), 1.88 (3H, s, 3-OAc), 2.73 (1H, br d, J = 16.9 Hz, H-4), 2.83 (1H, dd, 
J = 16.9, 4.6 Hz, H-4), 2.86 (1H, br d, J = 17.0 Hz, H-4''), 3.02 (1H, dd, J = 17.0, 4.5 Hz, 
H-4''), 4.37 (1H, s, H-2'), 4.87 (1H, br s, H-2), 5.29 (1H, m, H-3), 5.42 (1H, m, H-3''), 5.71 
(1H, br s, H-2''), 5.93, 5.96, 5.98, 6.00 (each 1H, d, J = 1.6 Hz, H-6, 8, 6'', 8''), 6.20 (1H, s, 
H-6'), 6.85 (1H, s, H-6'''); 13C NMR (125 MHz, acetone-d6) δ: 20.8, 20.9 (3-, 3''-OAc(CH3)), 
26.4 (C-4''), 26.6 (C-4), 45.5 (C-2'), 67.8 (C-3), 68.6 (C-3''), 74.3 (C-2''), 76.9 (C-2), 92.0 
(C-3'), 95.7, 95.8, 96.3, 96.8 (C-6, 8, 6'', 8''), 96.6 (C-4'), 98.5 (C-4a''), 98.6 (C-4a), 109.2 
(C-6'''), 111.9 (C-2'''), 122.9 (C-6'), 127.4 (C-1'''), 133.4 (C-4'''), 142.8 (C-3'''), 146.0 (C-5'''), 
155.4, 156.7, 157.1 (2C) (C-5, 8a, 5'', 8a''), 157.6 (2C, C-7, 7''), 162.0 (C-1'), 169.9 
(3-OAc(CO)), 170.6 (3''-OAc(CO)), 191.5 (C-5'); HMBC correlations (H to C): H-2/C-3, 4, 1', 
2', 6'; H-3/C-4a, 3-OAc(CO); H-4/C-2, 3, 4a, 5, 8a; H-2'/C-2, 1', 3', 4', 5' (4J), 6', 1''', 2''', 3''', 
4''' (4J); H-6'/C-2, 1', 2', 3' (4J), 4', 2''' (4J); H-2''/C-3'', 4'', 1''', 2''', 6'''; H-3''/C-4a'', 
3''-OAc(CO); H-4''/C-2'', 3'', 4a'', 5'', 8a''; H-6'''/C-2' (4J), 2'', 1''', 2''', 3''' (4J), 4''', 5'''; 
H-3-OAc/C-3 (4J), 3-OAc(CO); H-3''-OAc/C-3'' (4J), 3''-OAc(CO). 
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4.8.1.1. Reduction of 11 with dithiothreitol 
To a solution of 11 (55.5 mg, 78 μmol) in H2O (20 mL) was added dithiothreitol (50 mg) 
and the mixture was stirred at room temperature for 2 h. The solution was directly applied to 
MCI-gel CHP20P (2  23 cm) and eluted with 070% aq MeOH to give 11a (31.0 mg, 57%). 
A pale brown amorphous powder; [α]29D –76.4 (c 0.10, MeOH); FABMS m/z: 695 [M + H]
+; 
HRFABMS m/z: [M + H]+ calcd for C34H31O16, 695.1612; found: 695.1628; UV (MeOH) λmax 
nm (log ɛ): 209 (4.95), 236 sh (4.35), 274 sh (3.49); IR (dry film) νmax cm
–1: 3403, 1717, 1631, 
1518, 1467, 1378; 1H NMR (400 MHz, acetone-d6) δ: 1.88 (6H, s, Ac), 2.52 (2H, dd, J = 17.6, 
4.9 Hz, H-4), 2.73 (2H, br d, J = 17.6 Hz, H-4), 4.69 (2H, s, H-2), 5.13 (2H, m, H-3), 5.86, 
5.98 (each 2H, d, J = 2.2 Hz, H-6, 8), 6.78 (2H, s, H-6'), 7.03, 7.53, 7.90, 8.09, 8.26 (each 2H, 
br s, OH at C-5, 7, 3', 4', 5'); 13C NMR (100 MHz, acetone-d6) δ: 21.0 (Ac(CH3)), 26.4 (C-4), 
68.3 (C-3), 75.5 (C-2), 95.8, 96.5 (C-6, 8), 98.3 (C-4a), 107.9 (C-6'), 111.5 (C-2'), 129.1 
(C-1'), 133.9 (C-4'), 144.8, 146.5 (C-3’, 5’), 157.0, 157.3, 157.8 (C-5, 7, 8a), 171.3 (Ac(CO)). 
 
4.8.1.2. Acetylation of 11a 
A solution of 11a (20.3 mg, 29 μmol) in a mixture of acetic anhydride (0.5 mL) and pyridine 
(0.5 mL) was stirred for 20 h. After stirring, the solution was poured into ice-cold water and 
filtered. The filtered residue was purified by column chromatography on silica gel 
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(CHCl3MeOH, 100:098:2) to give 11b (20.5 mg, 63%). By the same procedure, acetylation 
of theasinensin C (14) (26.9 mg, 44 μmol) also afforded 11b (29.8 mg, 61%). A white 
amorphous powder; [α]33D 17.7 (c 0.12, CHCl3); MALDI-TOFMS m/z: 1137 [M + Na]+, 
1153 [M + K]+; Anal. Calcd for C54H50O26·H2O: C, 57.25; H, 4.63. Found: C, 57.33; H, 4.61; 
UV (MeOH) λmax nm (log ε): 206 (4.92), 270 (3.38); IR (dry film) νmax cm
–1: 2925, 2853, 
1771, 1744, 1624, 1593, 1487, 1438, 1370; 1H NMR (400 MHz, CDCl3) δ: 1.978, 1.985, 
2.228, 2.235, 2.25, 2.27 (each 6H, s, Ac), 2.72 (4H, br s, H-4), 4.61 (2H, s, H-2), 5.40 (2H, br 
s, H-3), 6.49, 6.53 (each 2H, d, J = 2.4 Hz, H-6, 8), 7.62 (2H, s, H-6'); 13C NMR (100 MHz, 
CDCl3)δ: 19.7, 20.1, 20.7, 20.7, 20.8, 21.0 (Ac(CH3)), 26.0 (C-4), 65.0 (C-3), 74.1 (C-2), 
108.0, 108.7, 109.7 (C-4a, 6, 8), 121.7, 122.9 (C-2', 6'), 134.7, 135.3 (C-1', 4'), 141.7, 143.6 
(C-3', 5'), 149.4, 149.5 (C-5, 7), 155.0 (C-8a), 166.5, 167.3, 167.6, 168.5, 169.0, 170.3 
(Ac(CO)). 
 
4.8.2. Compound 12 
A tan amorphous powder; [α]16D –33.7 (c 0.10, MeOH); FABMS m/z: 711 [M + H]
+; 
HRFABMS m/z: [M + H]+ calcd for C34H31O17, 711.1561; found, 711.1570; UV (MeOH) λmax 
nm (log ε): 206 (4.72), 228 sh (4.27), 268 sh (3.60); IR (dry film) νmax cm
–1: 3390, 1719, 1673, 
1629, 1607, 1519, 1469; 1H NMR (500 MHz, acetone-d6) δ: 1.87 (6H, s, Ac), 2.83 (2H, dd, J 
= 17.5, 2.0 Hz, H-4), 2.93 (2H, dd, J = 17.5, 4.7 Hz, H-4), 3.29 (2H, s, H-2'), 4.56 (2H, br s, 
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H-2), 5.63 (2H, m, H-3), 6.01, 6.07 (each 2H, d, J = 2.3 Hz, H-6, 8), 6.44 (2H, d, J = 1.6 Hz, 
H-6'); 13C NMR (125 MHz, acetone-d6) δ: 20.7 (Ac(CH3)), 25.7 (C-4), 59.9 (C-2'), 64.7 (C-3), 
76.4 (C-2), 85.4 (C-4'), 95.7, 96.8 (C-6, 8), 98.3 (C-4a), 104.7 (C-3'), 126.9 (C-6'), 155.3, 
157.2 (C-5, 8a), 156.6 (C-1'), 157.9 (C-7), 170.3 (Ac(CO)), 196.6 (C-5'); HMBC correlations 
(H to C): H-2/C-4, 1', 2', 6'; H-3/C-4, 4a, Ac(CO); H-4/C-2, 3, 4a, 5, 6 (4J), 8 (4J), 8a; H-6, 
8/C-4a, 7, 5 or 8a, 8 or 6; H-2'/C-2, 1', 3', 4', 5', 6'; H-6'/C-2, 1', 2', 3' (4J), 4'; H-Ac/C-3 (4J), 
Ac(CO). 
 
4.8.3. Compound 13a 
A pale yellow amorphous powder; [α]30D 61.5 (c 0.12, MeOH); FABMS m/z: 471 [M + H]+, 
493 [M + Na]+, 941 [2M + H]+; HRFABMS m/z: [M + H]+ calcd for C23H19O11, 471.0927; 
found: 471.0930; UV (MeOH) λmax nm (log ε): 277 sh (3.79), 300 (3.82), 346 sh (3.45); IR 
(dry film) νmax cm
–1: 3346, 1711, 1683, 1606, 1509, 1471, 1339; 1H NMR (500 MHz, 
acetone-d6) δ: 1.98 (3H, s, Ac), 2.85 (1H, dd, J = 17.5, 2.9 Hz, H-4), 3.00 (1H, d, J = 17.5, 4.9 
Hz, H-4), 4.48 (1H, s, H-e), 5.17 (1H, br s, H-2), 5.70 (1H, m, H-3), 5.93 (1H, br s, H-c), 6.14 
(1H, d, J = 2.3 Hz, H-6), 6.18 (1H, d, J = 2.3 Hz, H-8), 6.92 (1H, s, H-f); 13C NMR (125 MHz, 
acetone-d6) δ: 20.9 (Ac(CH3)), 25.9 (C-4), 55.7 (C-e), 66.5 (C-3), 74.0 (C-2), 85.4 (C-a), 95.9 
(C-8), 97.3 (C-6), 99.2 (C-8a), 106.8 (C-f), 114.2 (C-j), 126.0 (C-c), 133.0 (C-h), 143.2 (C-k), 
146.6 (C-g), 155.5 (C-8a), 156.1 (C-i), 157.6 (C-5), 158.1 (C-7), 170.7 (Ac(CO)), 174.9 (C-d), 
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198.7 (C-l), 200.7 (C-b); HMBC correlations (H to C): H-2/C-4, 8a, b (4J), c, d; H-3/C-4, 4a, 
d, Ac(CO); H-4/C-2, 3, 4a, 5, 6 (4J), 8 (4J), 8a; H-6/C-4a, 5, 7, 8; H-8/C-4a, 6, 7, 8a; H-c/C-2, 
a, b, d, e, k (4J); H-e/C-2, a, c, d, f, j, k, i (4J), l; H-f/C-d (4J), e, g, h, i (4J), j, k, l (4J); 
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Fig. 1. HPLC profile of the enzymatic oxidation products of epigallocatechin-3-O-gallate (1). 
Fig. 2. HPLC profile of the enzymatic oxidation products of epigallocatechin-3-O-acetate 
(10). 
Fig. 3. Structures of 11a, 11b, and 14. 
Scheme 1. Enzymatic oxidation of epigallocatechin-3-O-gallate (1). 
Scheme 2. Proposed mechanism of theacitrin C (5) production. 
Scheme 3. Degradation of theacitrin C (5) to afford theacitrinin A (6) and 
2,3,5,7-tetrahydroxychroman-3-O-gallate (7). 
Scheme 4. Proposed mechanism of theacitrinin B (9) production from theacitrin A (8). 
Scheme 5. Enzymatic oxidation of epigallocatechin-3-O-acetate (10). 
Scheme 6. Production pathways of proepitheaflagallin (20), theacitrin C (5), and theaflavins 
via bicyclo[3.2.1]octane-type intermediates. 
